Curcumin and targeting of molecular and metabolic pathways in multiple sclerosis
Cell Biochemistry and Function · 2023-10 · 41 (7) · 779-787
DOI: 10.1002/cbf.3841 ↗At a glance
Übersichtsarbeit in Cell Biochemistry and Function, published online on 2023-08-31. Written by Yalda Yazdani and 10 co-authors. Institution: Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Major MEDLINE topics: Curcumin, Multiple Sclerosis, Signal Transduction, Metabolic Networks and Pathways. Cited 23 times so far (Crossref); 110 references. Funded by: Tabriz University of Medical Sciences, Tabriz, Iran.
Abstract (original language)
Multiple sclerosis (MS) is a life‐threading disease that poses a great threat to the human being lifestyle. Having said extensive research in the realm of underlying mechanisms and treatment procedures, no definite remedy has been found. Over the past decades, many medicines have been disclosed to alleviate the symptoms and marking of MS. Meanwhile, the substantial efficacy of herbal medicines including curcumin must be underscored. Accumulated documents demonstrated the fundamental role of curcumin in the induction of the various signaling pathways. According to evidence, curcumin can play a role in mitochondrial dysfunction and apoptosis, autophagy, and mitophagy. Also, by targeting the signaling pathways AMPK, PGC‐1α/PPARγ, and PI3K/Akt/mTOR, curcumin interferes with the metabolism of MS. The anti‐inflammatory, antioxidant, and immune regulatory effects of this herbal compound are involved in its effectiveness against MS. Thus, the present review indicates the molecular and metabolic pathways associated with curcumin's various pharmacological actions on MS, as well as setting into context the many investigations that have noted curcumin‐mediated regulatory effects in MS.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Genetic, Tabriz Branch, Islamic Azad University, Tabriz, Iran.
- Department of Medical Laboratory Science, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran.
- Cellular and Molecular Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran.
- Department of Hematology, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran.
- Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
ORCID profiles: Aysan D Radvar
Funding
- Tabriz University of Medical Sciences, Tabriz, Iran
Cite
APA
Yazdani, Y., Zamani, A. R. N., Majidi, Z., Sharafkandi, N., Alizadeh, S., Mofrad, A. M. E., Valizadeh, A., Idari, G., Radvar, A. D., Safaie, N., & Faridvand, Y. (2023). Curcumin and targeting of molecular and metabolic pathways in multiple sclerosis. Cell Biochemistry and Function, 41(7), 779-787. https://doi.org/10.1002/cbf.3841
Vancouver
Yazdani Y, Zamani ARN, Majidi Z, Sharafkandi N, Alizadeh S, Mofrad AME, et al. Curcumin and targeting of molecular and metabolic pathways in multiple sclerosis. Cell Biochemistry and Function. 2023;41(7):779-787. doi:10.1002/cbf.3841
BibTeX
@article{Yazdani2023,
author = {Yazdani, Yalda and Zamani, Arezoo R N and Majidi, Ziba and Sharafkandi, Nadia and Alizadeh, Shaban and Mofrad, Amir M E and Valizadeh, Amir and Idari, Gholamreza and Radvar, Aysan D and Safaie, Nasser and Faridvand, Yousef},
title = {Curcumin and targeting of molecular and metabolic pathways in multiple sclerosis},
journal = {Cell Biochemistry and Function},
year = {2023},
volume = {41},
number = {7},
pages = {779--787},
doi = {10.1002/cbf.3841}
}
EUVIMED